gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · BAXHealthcareSurgical Instruments

Baxter International Inc. (BAX)

$26.50+3.96%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$26.91▲ 47.75% in range
Nov 3, 2025Low $15.80 · High $28.35Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Baxter International closed at $26.50 on Nov 4, up 3.96%, 6.5% below its 52-week closing high. Volume of 10.5M shares was 1.50× its 20-day average (above normal).

Split-adjusted performance: +8.8% over one month, +56.1% over six months, +45.5% over one year.

In the quarter ended Sep 30, 2026, revenue was $2.98B, up 5.0% from a year earlier, with a net margin of 9.9%.

Short interest was 23.8M shares at the Oct 15 settlement, down 2.5% from the prior report (4.6% of float, 4.2 days to cover).

Market cap$13.71B517.3M shares
Revenue · quarter$2.98B+5.0% YoY
Diluted EPS$0.57—
P/E · TTM—P/S 1.2×
Net margin9.9%Gross 33.4%
Dividend yield0.15%$0.01 last paid
52-week range15.80 – 28.35−6.5% from high
Volume10.5M1.50× 20-day avg
Volatility · 60d34.8%Annualised
Short % of float4.6%4.2 days to cover
Net cash-$6.63BCash $1.98B
Next earnings—Not scheduled
Split-adjusted performance
1W +4.1%1M +8.8%3M −1.9%6M +56.1%YTD +38.7%1Y +45.5%3Y −17.3%5Y −67.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum86
Revenue growth37
Net margin77
Value (low P/E)—
Size91

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short23.8M−2.5% vs prior
Days to cover4.2Settled Oct 15
% of float4.6%
Short vol. 10d60.4%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
BAXBaxter International$26.50+3.96%+56.1%+5.0%9.9%—$13.71B
GKOSGlaukos$246.70+5.86%+82.4%+58.0%1.0%—$14.60BCompare
PENPenumbra$322.45+0.76%−0.5%+15.6%10.3%80.9$12.71BCompare
SOLVSolventum$89.35+5.42%+25.9%+2.2%4.2%10.6$15.21BCompare
GMEDGLOBUS MEDICAL$87.10+9.45%−2.4%+5.9%19.2%21.8$11.69BCompare
PODDInsulet$165.02+6.56%+9.1%+23.5%11.8%30.5$11.44BCompare
WSTWest Pharmaceutical Services$408.78+0.44%+30.8%+8.7%24.5%44.6$28.48BCompare
TFXTeleflex Incorporated$149.87+7.09%+21.6%+28.9%17.5%—$6.35BCompare
HAEHaemonetics$127.42+5.94%+141.9%+5.6%9.7%60.2$5.80BCompare

News about Baxter International

All news →
Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook RaisedZacks Investment Research · 6d ago▲ PositiveWill Baxter's Q3 Earnings Show Progress Despite Cost Pressures?Zacks Investment Research · Oct 26, 2026▼ NegativeAre Investors Undervaluing Baxter International (BAX) Right Now?Zacks Investment Research · Oct 6, 2026▲ PositiveIs Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research · Oct 6, 2026▲ PositiveDrug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHAGlobeNewswire Inc. · Sep 7, 2026▲ Positive

Quick answers

What does Baxter International do?
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
What is BAX's market cap?
$13.71B, based on the Nov 4 close of $26.50.
Does Baxter International pay a dividend?
Yes. The latest regular dividend was $0.01 per share (ex-date Aug 28), an annualised yield of 0.15%.
How much of BAX is sold short?
23.8M shares, 4.6% of float, as of Oct 15, 2026.
What sector is BAX in?
Healthcare, in the Surgical Instruments industry.

About Baxter International

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

HQ: Deerfield, IL37,500 employeesListed May 15, 1961baxter.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology